Loading
Oral Health in Cancer Treatment · Journal article
Bali Medical and Wellness Journal · August 16, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a descriptive case report of nutritional intervention in a 66-year-old woman with colon non-Hodgkin lymphoma and treatment-related malnutrition, infectious complications, and electrolyte disturbances. The report documents the clinical application of ESPEN guidelines through texture modification, peptide-based enteral supplementation, and micronutrient support, but provides no quantified outcome data, follow-up results, or comparison to standard care.
Single case report. One 66-year-old woman with ascending colon non-Hodgkin lymphoma hospitalised during fourth cycle of R-CHOP chemotherapy with pneumonia, oroesophageal candidiasis, suspected pneumonitis, electrolyte disturbances, and malnutrition.. Intervention: Nutritional therapy comprising blenderized meals three times daily (2100 kcal, 70 g protein/day), peptide-based enteral formula supplementation, virgin coconut oil, zinc supplementation, and vitamin C supplementation..
Patient presented with 10.6% weight loss during chemotherapy and BMI 19.2 kg/m² indicating malnutrition risk Clinical presentation included pneumonia, oroesophageal candidiasis, suspected pneumonitis, and electrolyte disturbances (Na 129 mmol/L; K 3.2 mmol/L) Nutritional therapy targets set at 2100 kcal and 70 g protein/day delivered via blenderized meals three times daily plus peptide-based enteral formula, virgin coconut oil, and zinc and vitamin C supplementation
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This case illustrates a structured approach to nutritional support in a cancer patient with multiple comorbidities and treatment-related toxicities; however, the absence of quantified clinical outcomes, recovery timeline, or comparisons to alternative management prevents assessment of whether this specific nutritional strategy improves survival, functional status, or infection resolution relative to standard care.
Single case report describing nutritional intervention application in a complex cancer patient; demonstrates feasibility and clinical reasoning but lacks comparator, control group, and quantified outcome measures.
As stated by the source record.
Quoted from the source exactly as published.
This case illustrates a structured approach to nutritional support in a cancer patient with multiple comorbidities and treatment-related toxicities; however, the absence of quantified clinical outcomes, recovery timeline, or comparisons to alternative management prevents assessment of whether this specific nutritional strategy improves survival, functional status, or infection resolution relative to standard care.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background: Malnutrition is a frequent complication in patients with cancer undergoing chemotherapy due to increased metabolic requirements, treatment-related adverse effects, and infectious complications. Gastrointestinal disturbances such as nausea, dysphagia, and opportunistic infections may worsen food intake and increase the risk of malnutrition. Case Description: A 66-year-old woman with ascending colon non-Hodgkin lymphoma undergoing the fourth cycle of R-CHOP chemotherapy was hospitalized with pneumonia, oroesophageal candidiasis, suspected pneumonitis, electrolyte disturbances (Na 129 mmol/L; K 3.2 mmol/L), and mild anemia (Hb 9.8 g/dL). Nutritional assessment showed a body mass index of 19.2 kg/m2 with approximately 10.6% weight loss during the chemotherapy period, indicating a risk of malnutrition. Nutritional therapy was provided gradually as a high-energy, high-protein diet with targets of 2100 kcal and 70 g protein/day, in the form of blenderized meals three times daily, together with peptide-based enteral formula supplementation, additional virgin coconut oil, and zinc and vitamin C supplementation. Discussion: Texture modification was intended to improve oral tolerance and minimize discomfort during swallowing, whereas the peptide-based formula was selected because it may be more easily absorbed when gastrointestinal function is impaired. The addition of virgin coconut oil as a source of medium-chain triglycerides provided energy that is rapidly metabolized without complex emulsification. Zinc and vitamin C supplementation was expected to support immune response, reduce oxidative stress, and accelerate the healing of mucosa inflamed due to infection and chemotherapy-related effects. Conclusion: A combination of food texture modification, peptide-based formula, and rapidly absorbed energy sources is a rational strategy to maintain nutritional adequacy and prevent worsening nutritional status during chemotherapy. Keywords: non-Hodgkin lymphoma, chemotherapy, malnutrition, ESPEN
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.